Ciprian Vasile Pojala, Sebastian Toma, Cristea Costache, Tunde Peter, Cristiana Elena Pojala, Nadinne Alexandra Roman, Lorena Dima
{"title":"The Potential of Intra-Articular Therapies in Managing Knee Osteoarthritis: A Systematic Review.","authors":"Ciprian Vasile Pojala, Sebastian Toma, Cristea Costache, Tunde Peter, Cristiana Elena Pojala, Nadinne Alexandra Roman, Lorena Dima","doi":"10.3390/clinpract14050157","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Knee osteoarthritis (KOA) is a common degenerative and progressive joint disorder that negatively influences patients' quality of life. Intra-articular therapies, such as hyaluronic acid (HA) and platelet-rich plasma (PRP), have garnered attention for their potential to manage osteoarthritis OA symptoms effectively. This systematic review aims to identify the effectiveness and safety of HA and PRP treatment modalities in treating KOA.</p><p><strong>Methods: </strong>A literature search was conducted across MEDLINE (PubMed), Web of Science Core Collection, and Science Direct Collection Elsevier. Twenty-three randomized controlled trials, cohort studies, and observational studies were included in the review. The selection criteria focused on studies published in English within the last 10 years, involving subjects with KOA treated with intra-articular injections of HA or PRP and reporting on pain, function, or overall treatment efficacy outcomes.</p><p><strong>Results: </strong>The analysis showed that both HA and PRP significantly improve functionality and reduce pain in KOA patients. High molecular weight HA consistently reduced pain and improved joint mobility in various studies. PRP had better long-term outcomes when combined with HA, leading to greater pain reduction and functional improvement. Both therapies had generally favorable safety profiles, with only minor adverse events reported. However, there were potential biases identified across the studies, such as selection, performance, detection, and reporting biases, which impacted the reliability of the results.</p><p><strong>Conclusions: </strong>Intra-articular treatments with HA and PRP show promise in managing knee osteoarthritis, with personalized treatment plans and further research needed to confirm these findings.</p>","PeriodicalId":45306,"journal":{"name":"Clinics and Practice","volume":"14 5","pages":"1970-1996"},"PeriodicalIF":1.7000,"publicationDate":"2024-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11506573/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinics and Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/clinpract14050157","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Knee osteoarthritis (KOA) is a common degenerative and progressive joint disorder that negatively influences patients' quality of life. Intra-articular therapies, such as hyaluronic acid (HA) and platelet-rich plasma (PRP), have garnered attention for their potential to manage osteoarthritis OA symptoms effectively. This systematic review aims to identify the effectiveness and safety of HA and PRP treatment modalities in treating KOA.
Methods: A literature search was conducted across MEDLINE (PubMed), Web of Science Core Collection, and Science Direct Collection Elsevier. Twenty-three randomized controlled trials, cohort studies, and observational studies were included in the review. The selection criteria focused on studies published in English within the last 10 years, involving subjects with KOA treated with intra-articular injections of HA or PRP and reporting on pain, function, or overall treatment efficacy outcomes.
Results: The analysis showed that both HA and PRP significantly improve functionality and reduce pain in KOA patients. High molecular weight HA consistently reduced pain and improved joint mobility in various studies. PRP had better long-term outcomes when combined with HA, leading to greater pain reduction and functional improvement. Both therapies had generally favorable safety profiles, with only minor adverse events reported. However, there were potential biases identified across the studies, such as selection, performance, detection, and reporting biases, which impacted the reliability of the results.
Conclusions: Intra-articular treatments with HA and PRP show promise in managing knee osteoarthritis, with personalized treatment plans and further research needed to confirm these findings.
背景:膝关节骨性关节炎(KOA)是一种常见的退行性和渐进性关节疾病,对患者的生活质量有负面影响。透明质酸(HA)和富血小板血浆(PRP)等关节内疗法因其有效控制骨关节炎 OA 症状的潜力而备受关注。本系统综述旨在确定HA和PRP治疗模式在治疗KOA方面的有效性和安全性:方法:在MEDLINE(PubMed)、Web of Science Core Collection和Science Direct Collection Elsevier中进行文献检索。23项随机对照试验、队列研究和观察性研究被纳入综述。选择标准集中在过去 10 年内发表的英文研究,涉及接受 HA 或 PRP 关节内注射治疗的 KOA 受试者,并报告了疼痛、功能或总体治疗效果:结果:分析表明,HA 和 PRP 都能显著改善 KOA 患者的功能并减轻疼痛。在多项研究中,高分子量 HA 可持续减轻疼痛并改善关节活动度。当 PRP 与 HA 结合使用时,长期疗效更好,疼痛减轻和功能改善的幅度更大。这两种疗法的安全性普遍良好,仅有轻微不良反应的报道。不过,在各项研究中也发现了一些潜在的偏差,如选择偏差、表现偏差、检测偏差和报告偏差,这些都影响了研究结果的可靠性:结论:使用HA和PRP进行关节内治疗显示出治疗膝关节骨性关节炎的前景,但还需要个性化的治疗方案和进一步的研究来证实这些发现。